Summary Table. The parties agree that the following table (the “Table”) sets forth in summary form the basic terms of this Lease, including the specific space comprising the Premises and, with respect to such space, the Term of the Lease, the usable and rentable square footage, the Base Rent, Base Year, and Tenant’s Share, as all of such terms are defined below: Commencement Date to January 31, 2005 Suite 400 Commencement Date to January 31, 2005 400 8,448 $ 14,784.00 3.630 % 1.819 % 2004 February 1, 2005 to January 31, 2006 400 8,448 $ 15,206.40 3.630 % 1.819 % 2004 February 1, 2006 to January 31, 2007 400 8,448 $ 15,628.80 3.630 % 1.819 % 2004 February 1, 2007 to January 31, 2008 400 8,448 $ 16,051.20 3.630 % 1.819 % 2004 February 1, 2008 to January 31, 2009 400 8,448 $ 16,473.60 3.630 % 1.819 % 2004 February 1, 2009 to January 31, 2010 400 8,448 $ 16,896.00 3.630 % 1.819 % 2004 February 1, 2010 to January 31, 2011 400 8,448 $ 17,318.40 3.630 % 1.819 % 2004 February 1, 2011 to January 31, 2012 400 8,448 $ 17,740.80 3.630 % 1.819 % 2004 February 1, 2012 to January 31, 2013 400 8,448 $ 18,163.20 3.630 % 1.819 % 2004 February 1, 2013 to January 31, 2014 400 8,448 $ 18,585.60 3.630 % 1.819 % 2004 TOTALS: In the event of any conflict between the terms contained in the Table and the terms contained in subsequent sections of the Lease, the terms of the Table shall control, except that any dates stated in the Table are subject to adjustment as appropriate to the extent any other provisions of the Lease provide for adjustments to the Commencement Date and/or the Expiration Date and subject to the rental abatement provided in § 1.6.3 below.
Appears in 2 contracts
Sources: Commercial Sublease Agreement (Sunesis Pharmaceuticals Inc), Commercial Sublease Agreement (Sunesis Pharmaceuticals Inc)